Evaluation of recent New Vaccine Surveillance Network data regarding respiratory syncytial virus hospitalization rates in US preterm infants

References

• Hall CB, Weinberg GA, Blumkin AK, Edwards KM, Staat MA, Schultz AF, Poehling KA, Szilagyi PG, Griffin MR, Williams JV, et al. Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age. Pediatrics 2013; 132:e341-8; PMID:23878043; http://dx.doi.org/10.1542/peds.2013-0303
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. New Vaccine Surveillance Network (NVSN). Available at: http://www.cdc.gov/surveillance/nvsn/index.html. Accessed March 31, 2015.
   Google Scholar
• Ambrose CS, Caspard H, Rizzo C, Stepka EC, Keenan G. Standard methods based on last menstrual period dates misclassify and overestimate US preterm births. J Perinatol 2015; 35:411-4; PMID:25836319; http://dx.doi.org/10.1038/jp.2015.25
   PubMed Web of Science ®Google Scholar
• Blanken MO, Rovers MM, Molenaar JM, Winkler-Seinstra PL, Meijer A, Kimpen JL, Bont L. Dutch RSV Neonatal Network. Respiratory syncytial virus and recurrent wheeze in healthy preterm infants. N Engl J Med 2013; 368:1791-9; PMID:23656644; http://dx.doi.org/10.1056/NEJMoa1211917
   PubMed Web of Science ®Google Scholar
• The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102:531-7; PMID:9738173; http://dx.doi.org/10.1542/peds.102.3.531
   PubMed Web of Science ®Google Scholar
• Groothuis JR, Simoes EA, Levin MJ, Hall CB, Long CE, Rodriguez WJ, Arrobio J, Meissner HC, Fulton DR, Welliver RC, et al. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med 1993; 329:1524-30; PMID:8413475; http://dx.doi.org/10.1056/NEJM199311183292102
   PubMed Web of Science ®Google Scholar
• Meissner HC, Long SS, American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 2003; 112:1447-52; PMID:14654628.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics 2003; 112:1442-6; PMID:14654627.
   PubMed Web of Science ®Google Scholar
• The PREVENT Study Group. Reduction of RSV hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. Pediatrics 1997; 99:93-9; PMID:8989345; http://dx.doi.org/10.1542/peds.99.1.93
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics. Red Book: Report of the Committee on Infectious Diseases. 25th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2000.
   Google Scholar
• Carroll KN, Griffin MR, Edwards KM, Ali A, Zhu Y, Iwane MK, Szilagyi PG, Staat MA, Stevens TP, Hall CB, et al. Adherence to guidelines for respiratory syncytial virus immunoprophylaxis among infants with prematurity or chronic lung disease in three United States counties. Pediatr Infect Dis J 2012; 31:e229-231; PMID:22760537; http://dx.doi.org/10.1097/INF.0b013e318266bf89
   PubMed Web of Science ®Google Scholar
• Hampp C, Saidi AS, Winterstein AG. Palivizumab utilization and compliance: trends in respiratory syncytial virus prophylaxis in Florida. J Pediatr 2010; 156:953-9, 959 e951; PMID:20223478; http://dx.doi.org/10.1016/j.jpeds.2009.12.016
   PubMed Web of Science ®Google Scholar
• La Gamma EF, Kumar VR, Wadhawan R, Ye S, Sifakis F, Ycas J, Ambrose CS. Receipt of palivizumab before birth hospitalization discharge among preterm infants in the United States. Am J Perinatol 2015; 32:1017-23; PMID:25877742; http://dx.doi.org/10.1055/s-0034-1543951
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Natality data summary. Available at: http://wonder.cdc.gov/wonder/help/natality.html. Accessed April 1, 2015.
   Google Scholar
• Committee on Infectious Diseases and Bronchiolitis Guidelines Committee. Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 2014; 134:415-20
   PubMed Web of Science ®Google Scholar
• Boyce TG, Mellen BG, Mitchel EF, Jr., Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000; 137:865-70; PMID:11113845; http://dx.doi.org/10.1067/mpd.2000.110531
   PubMed Web of Science ®Google Scholar
• Carbonell-Estrany X, Quero J, IRIS Study Group. Hospitalization rates for respiratory syncytial virus infection in premature infants born during two consecutive seasons. Pediatr Infect Dis J 2001; 20:874-9; PMID:11734767; http://dx.doi.org/10.1097/00006454-200109000-00010
   PubMed Web of Science ®Google Scholar
• Horn SD, Smout RJ. Effect of prematurity on respiratory syncytial virus hospital resource use and outcomes. J Pediatr 2003; 143:S133-141; PMID:14615712; http://dx.doi.org/10.1067/S0022-3476(03)00509-2
   PubMedGoogle Scholar
• Lanari M, Silvestri M, Rossi GA. Respiratory syncytial virus risk factors in late preterm infants. J Matern Fetal Neonatal Med 2009; 22 Suppl 3:102-7; PMID:19925369; http://dx.doi.org/10.1080/14767050903194438
   PubMed Web of Science ®Google Scholar
• Liese JG, Grill E, Fischer B, Roeckl-Wiedmann I, Carr D, Belohradsky BH. Incidence and risk factors of respiratory syncytial virus-related hospitalizations in premature infants in Germany. Eur J Pediatr 2003; 162:230-6; PMID:12647195.
   PubMed Web of Science ®Google Scholar
• Meert K, Heidemann S, Abella B, Sarnaik A. Does prematurity alter the course of respiratory syncytial virus infection? Crit Care Med 1990; 18:1357-9; PMID:2245609; http://dx.doi.org/10.1097/00003246-199012000-00009
   PubMed Web of Science ®Google Scholar
• Resch B, Pasnocht A, Gusenleitner W, Muller W. Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age. J Infect 2005; 50:397-403; PMID:15907547; http://dx.doi.org/10.1016/j.jinf.2004.06.015
   PubMed Web of Science ®Google Scholar
• Stevens TP, Sinkin RA, Hall CB, Maniscalco WM, McConnochie KM. Respiratory syncytial virus and premature infants born at 32 weeks' gestation or earlier: hospitalization and economic implications of prophylaxis. Arch Pediatr Adolesc Med 2000; 154:55-61; PMID:10632251.
   PubMed Web of Science ®Google Scholar
• Eriksson M, Bennet R, Rotzen-Ostlund M, Von Sydow M, Wirgart BZ. Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatr 2002; 91:593-8; PMID:12113331; http://dx.doi.org/10.1111/j.1651-2227.2002.tb03282.x
   PubMed Web of Science ®Google Scholar
• Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, Auinger P, Griffin MR, Poehling KA, Erdman D, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360:588-98; PMID:19196675; http://dx.doi.org/10.1056/NEJMoa0804877
   PubMed Web of Science ®Google Scholar
• Joffe S, Escobar G, Black S, Armstrong M, Lieu T. Rehospitalization for respiratory syncytial virus among premature infants. Pediatrics 1999; 104:894-9; PMID:10506231.
   PubMed Web of Science ®Google Scholar
• Leader S, Kohlhase K. Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003; 143:S127-132; PMID:14615711; http://dx.doi.org/10.1067/S0022-3476(03)00510-9
   PubMed Web of Science ®Google Scholar
• Resch B, Paes B. Are late preterm infants as susceptible to RSV infection as full term infants? Early Hum Dev 2011; 87 Suppl 1:S47-49; PMID:21276672; http://dx.doi.org/10.1016/j.earlhumdev.2011.01.010
   PubMed Web of Science ®Google Scholar
• Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995; 126:212-19; PMID:7844667; http://dx.doi.org/10.1016/S0022-3476(95)70547-3
   PubMed Web of Science ®Google Scholar
• Weisman LE. Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions. Pediatr Infect Dis J 2003; 22:S33-37; discussion S37-39; PMID:12671450
   PubMed Web of Science ®Google Scholar
• Meert K, Heidemann S, Lieh-Lai M, Sarnaik AP. Clinical characteristics of respiratory syncytial virus infections in healthy versus previously compromised host. Pediatr Pulmonol 1989; 7:167-70; PMID:2797931; http://dx.doi.org/10.1002/ppul.1950070309
   PubMed Web of Science ®Google Scholar
• Wilkesmann A, Ammann RA, Schildgen O, Eis-Hubinger AM, Muller A, Seidenberg J, Stephan V, Rieger C, Herting E, Wygold T, et al. Hospitalized children with respiratory syncytial virus infection and neuromuscular impairment face an increased risk of a complicated course. Pediatr Infect Dis J 2007; 26:485-91; PMID:17529864; http://dx.doi.org/10.1097/INF.0b013e31805d01e3
   PubMed Web of Science ®Google Scholar
• Fauroux B, Gouyon JB, Roze JC, Guillermet-Fromentin C, Glorieux I, Adamon L, Di Maio M, Anghelescu D, Miloradovich T, Escande B, et al. Respiratory morbidity of preterm infants of less than 33 weeks gestation without bronchopulmonary dysplasia: a 12-month follow-up of the CASTOR study cohort. Epidemiol Infect 2014; 142:1362-74; PMID:24029023; http://dx.doi.org/10.1017/S0950268813001738
   PubMed Web of Science ®Google Scholar
• Dougherty NN, Meissner HC. Respiratory syncytial virus immunoprophylaxis: impact on epidemiology. Paediatr Drugs 2000; 2:127-32; PMID:10937464; http://dx.doi.org/10.2165/00148581-200002020-00005
   PubMedGoogle Scholar
• Fodha I, Vabret A, Ghedira L, Seboui H, Chouchane S, Dewar J, Gueddiche N, Trabelsi A, Boujaafar N, Freymuth F. Respiratory syncytial virus infections in hospitalized infants: association between viral load, virus subgroup, and disease severity. J Med Virol 2007; 79:1951-8; PMID:17935185; http://dx.doi.org/10.1002/jmv.21026
   PubMed Web of Science ®Google Scholar
• Moler FW, Steinhart CM, Ohmit SE, Stidham GL. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group. J Pediatr 1996; 128:422-8; PMID:8774517; http://dx.doi.org/10.1016/S0022-3476(96)70294-9
   PubMed Web of Science ®Google Scholar
• Palmer L, Hall CB, Katkin JP, Shi N, Masaquel AS, McLaurin KK, Mahadevia PJ. Healthcare costs within a year of respiratory syncytial virus among Medicaid infants. Pediatr Pulmonol 2010; 45:772-81; PMID:20632403; http://dx.doi.org/10.1002/ppul.21244
   PubMed Web of Science ®Google Scholar
• Ambrose CS, Anderson EJ, Simoes EA, Wu X, Elhefni H, Park CL, Sifakis F, Groothuis JR. Respiratory syncytial virus disease in preterm infants in the United States born at 32–35 weeks gestation not receiving immunoprophylaxis. Pediatr Infect Dis J 2014; 33:576-82; PMID:24622396; http://dx.doi.org/10.1097/INF.0000000000000219
   PubMed Web of Science ®Google Scholar
• Escobar GJ, Gebretsadik T, Carroll K, Li SX, Walsh EM, Wu P, Mitchel E, Sloan C, Hartert T. Adherence to immunoprophylaxis regimens for respiratory syncytial virus infection in insured and medicaid populations. J Pediatric Infect Dis Soc 2013; 2:205-14; PMID:24921044; http://dx.doi.org/10.1093/jpids/pit007
   PubMedGoogle Scholar
• Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH, Jr., Connor EM, Sondheimer HM, Cardiac Synagis Study Group. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 2003; 143:532-40; PMID:14571236; http://dx.doi.org/10.1067/S0022-3476(03)00454-2
   PubMed Web of Science ®Google Scholar
• Fryzek JP, Martone WJ, Groothuis JR. Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study. Adv Ther 2011; 28:195-201; PMID:21327753; http://dx.doi.org/10.1007/s12325-010-0106-6
   PubMed Web of Science ®Google Scholar
• Gooch KL, Notario GF, Schulz G, Gudkov KM, Buesch K, Khong H, Campbell A. Comparison of risk factors between preterm and term infants hospitalized for severe respiratory syncytial virus in the Russian Federation. Int J Womens Health 2011; 3:133-8; PMID:21792335; http://dx.doi.org/10.2147/IJWH.S16608
   PubMedGoogle Scholar
• Winterstein AG, Knox CA, Kubilis P, Hampp C. Appropriateness of age thresholds for respiratory syncytial virus immunoprophylaxis in moderate-preterm infants: A cohort study. JAMA Pediatr 167:1118-24; PMID:24126903; http://dx.doi.org/10.1001/jamapediatrics.2013.2636
   PubMed Web of Science ®Google Scholar
• Langley GF, Anderson LJ. Epidemiology and prevention of respiratory syncytial virus infections among infants and young children. Pediatr Infect Dis J 2011; 30:510-7; PMID:21487331
   PubMed Web of Science ®Google Scholar
• Heikkinen T, Valkonen H, Lehtonen L, Vainionpaa R, Ruuskanen O. Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis. Arch Dis Child Fetal Neonatal Ed 2005; 90:F64-68; PMID:15613580; http://dx.doi.org/10.1136/adc.2003.029710
   PubMedGoogle Scholar
• Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 2003; 88:1065-9; PMID:14670770; http://dx.doi.org/10.1136/adc.88.12.1065
   PubMed Web of Science ®Google Scholar
• Gouyon JB, Roze JC, Guillermet-Fromentin C, Glorieux I, Adamon L, Di Maio M, Miloradovich T, Anghelescu D, Pinquier D, Escande B, et al. Hospitalizations for respiratory syncytial virus bronchiolitis in preterm infants at Epidemiol Infect 2013; 141:816-26; PMID:22697130; http://dx.doi.org/10.1017/S0950268812001069
   PubMed Web of Science ®Google Scholar
• Boyce TG, DeVincenzo J, Piedra PA. Updated RSV guidelines misinterpret available data [Letter to the Editor]. Pediatrics 2014. Available at: http://pediatrics.aappublications.org/content/early/2014/07/23/peds.2014-1665.comments#-updated-rsv-guidelines-misinterpret-available-data-. Accessed Oct 20, 2015.
   Google Scholar